Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Opinion in Pharmacology|February 7, 2007
Sphingosine-1-phosphate signaling in the cardiovascular systemStephan L M Peters, Astrid E Alewijnse
European Journal of Pharmacology|April 19, 2008
Sphingolipid signalling in the cardiovascular system: good, bad or both?Astrid E Alewijnse, Stephan L M Peters
Trends in Pharmacological Sciences|July 28, 2006
Rho kinase: a target for treating urinary bladder dysfunction?Stephan L M Peters, Martina Schmidt, Martin C Michel
Molecules and Cells|February 4, 2010
Sphingosine-1-phosphate receptors: zooming in on ligand-induced intracellular trafficking and its functional implicationsDennis Verzijl, Stephan L M Peters, Astrid E Alewijnse
Journal of Veterinary Internal Medicine|November 15, 2015
Cytological Findings of 140 Bile Samples from Dogs and Cats and Associated Clinical Pathological DataL M Peters, B Glanemann, O A Garden, et al.
British Journal of Pharmacology|October 27, 2004
Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolitesAstrid E Alewijnse, Stephan L M Peters, Martin C Michel
Molecules and Cells|February 4, 2010
Sphingolipids and the orchestration of endothelium-derived vasoactive factors: when endothelial function demands greasingLéon J A Spijkers, Astrid E Alewijnse, Stephan L M Peters
British Journal of Pharmacology|January 19, 2012
FTY720 (fingolimod) increases vascular tone and blood pressure in spontaneously hypertensive rats via inhibition of sphingosine kinaseLéon J A Spijkers, Astrid E Alewijnse, Stephan L M Peters
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 7, 2003
The influence of endogenously generated reactive oxygen species on the inotropic and chronotropic effects of adrenoceptor and ET-receptor stimulationCarsten Sand, Stephan L M Peters, Martin Pfaffendorf, et al.
Pageof 7